Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease).
Moyon Q, Pineton de Chambrun M, Gousseff M, Mathian A, Hie M, Urbanski G, Verlicchi F, Faguer S, Dossier A, Lega JC, Riviere S, Saadoun D, Graveleau J, Lucchini-Lecomte MJ, Christides C, Le Moal S, Bibes B, Malizia G, Ruivard M, Blaison G, Alric L, Agard C, Soubrier M, Viallard JF, Levesque H, Rivard GE, Tieulie N, Hot A, Lovey PY, Hanslik T, Lhote F, Eble V, Álvarez Troncoso J, Aujayeb A, Quentric P, Taieb D, Cohen-Aubart F, Lambert M, Amoura Z; EurêClark Study Group. Moyon Q, et al. Among authors: faguer s. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2889-2895. doi: 10.1016/j.jaip.2022.07.006. Epub 2022 Jul 21. J Allergy Clin Immunol Pract. 2022. PMID: 35870726
Rituximab in anti-GBM disease: A retrospective study of 8 patients.
Touzot M, Poisson J, Faguer S, Ribes D, Cohen P, Geffray L, Anguel N, François H, Karras A, Cacoub P, Durrbach A, Saadoun D. Touzot M, et al. Among authors: faguer s. J Autoimmun. 2015 Jun;60:74-9. doi: 10.1016/j.jaut.2015.04.003. Epub 2015 May 4. J Autoimmun. 2015. PMID: 25953709
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Among authors: faguer s. Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Ann Rheum Dis. 2018. PMID: 29695500 Clinical Trial.
CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Combes A, Luyt CE, Amoura Z; SAPHIR study group. Pineton de Chambrun M, et al. Among authors: faguer s. J Autoimmun. 2019 Sep;103:102292. doi: 10.1016/j.jaut.2019.06.003. Epub 2019 Jun 26. J Autoimmun. 2019. PMID: 31253464
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.
Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D. Marques C, et al. Among authors: faguer s. Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019. Front Immunol. 2019. PMID: 31396214 Free PMC article.
In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Luyt CE, Combes A, Amoura Z. Pineton de Chambrun M, et al. Among authors: faguer s. Chest. 2020 May;157(5):1158-1166. doi: 10.1016/j.chest.2019.11.010. Epub 2019 Nov 26. Chest. 2020. PMID: 31783015 Free article.
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis.
Charles P, Dechartres A, Terrier B, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Among authors: faguer s. Rheumatology (Oxford). 2020 Oct 1;59(10):2970-2975. doi: 10.1093/rheumatology/kez621. Rheumatology (Oxford). 2020. PMID: 32150263 Free article. Clinical Trial.
Corrigendum to: Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis.
Charles P, Dechartres A, Terrier B, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Among authors: faguer s. Rheumatology (Oxford). 2020 Oct 1;59(10):3119. doi: 10.1093/rheumatology/keaa222. Rheumatology (Oxford). 2020. PMID: 32447394 No abstract available.
Impact of aging on phenotype and prognosis in IgA vasculitis.
Audemard-Verger A, Pillebout E, Baldolli A, Gouellec NL, Augusto JF, Jourde-Chiche N, Raffray L, Thervet E, Deroux A, Goutte J, Hummel A, Lioger B, Sanges S, Cacoub P, Amoura Z, Moulis G, Maurier F, Lavigne C, Urbanski G, Chanal J, Faguer S, Deriaz S, Feirreira-Maldent N, Diot E, Maillot F, Guillevin L, Terrier B. Audemard-Verger A, et al. Among authors: faguer s. Rheumatology (Oxford). 2021 Sep 1;60(9):4245-4251. doi: 10.1093/rheumatology/keaa921. Rheumatology (Oxford). 2021. PMID: 33410479
The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease).
Pineton de Chambrun M, Moyon Q, Faguer S, Urbanski G, Mathian A, Zucman N, Werner M, Luyt CE, Verlicchi F, Amoura Z; EurêClark Study Group. Pineton de Chambrun M, et al. Among authors: faguer s. J Allergy Clin Immunol Pract. 2022 Feb;10(2):626-629. doi: 10.1016/j.jaip.2021.11.023. Epub 2021 Dec 7. J Allergy Clin Immunol Pract. 2022. PMID: 34890829 Free PMC article. No abstract available.
191 results